Intravenous and oral practolol in the acute stages of myocardial infarction.

Abstract

The influence of routine administration of the beta adrenoceptor blocking drug practolol on the outcome of acute myocardial infarction has been studied in 94 patients. The study was restricted to patients under the age of 70 experiencing their first myocardial infarction and in whom there was no contraindication to beta blockade. In the treated group an initial dose intravenous practolol 15 mg was followed by five oral doses of practolol 200 mg at 12 h intervals. A significant reduction in heart rate and systolic blood pressure was apparent in the treated group within 2 h. No difference was detectable in the course of the acute stage of the illness between treated and control patients, apart from a significant reduction in the incidence of atrial fibrillation among those receiving practolol. Patients with inferior infarctions showed a tendency to develop potentially harmful bradycardia and hypotension on receiving practolol which lead to withdrawal of the drug in many cases. At regular review over 7 mth no detectable difference emerged between the treated and control groups in the incidence of cardiac failure, death or reinfarction.

• Authors: K L Evemy, B L Pentecost
• Journal: European journal of cardiology (Eur J Cardiol) Vol. 7 Issue 5-6 Pg. 391-8 (Jul 1978) ISSN: 0301-4711 [Print] Netherlands
• PMID: 699938 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)

Chemical References

• Practolol

Topics

• Acute Disease
• Aged
• Arrhythmias, Cardiac (prevention & control)
• Blood Pressure (drug effects)
• Dose-Response Relationship, Drug
• Follow-Up Studies
• Heart Rate (drug effects)
• Humans
• Male
• Middle Aged
• Myocardial Infarction (complications, drug therapy)
• Practolol (therapeutic use)